Professor Imam Waked is Professor of Medicine and Hepatology and Dean Emeritus of the National Liver Institute in Egypt where he founded and continues to direct the Clinical Research Unit. He graduated from Cairo University School of Medicine, earned his Doctorate degree from Ain Shams University in Cairo, and completed advanced training in the liver unit at the University of Southern California. He is an elected Fellow of the Royal College of Physicians in London (FRCP)—honored with a Fellowship despite not being a member of the College—and a Fellow of the American Association for the Study of Liver Diseases (FAASLD). He is a board member of the Egyptian National Committee for Control of Viral Hepatitis (NCCVH), the committee responsible for the elimination of hepatitis C in Egypt, and for setting the management guidelines and overseeing implementation of national diagnosis and treatment policies for viral hepatitis and hepatocellular carcinoma. He heads the NCCVH’s research and publication committee, is a member of the HCC surveillance and management board, and is member of national guidelines writing committee (guidelines for HCC, HCV and HBV). Professor Waked is a member and previous Chair of the Technical Advisory Board of the Coalition for Global Hepatitis Elimination (CGHE), a component of the of the Task Force for Global Health (an official non-state actor of the World Health Organization [WHO]). His cancer related research and publications have focused on HCC; its prevention, early detection, diagnosis, and management. These efforts have contributed to advancing liver cancer care and research in Egypt, where the incidence of HCC is the highest among Arab countries and among the highest globally, and research collaboration in the Arab world.